MiR-29b was significantly reduced in bortezomib-resistant cells as well as in cells resistant to second-generation PIs carfilzomib and ixazomib. Luciferase reporter assays demonstrated that miR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results